Jasper Therapeutics JSPR
NASDAQ JSPR
$0.51 +0.01 (+2.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Jasper Therapeutics (JSPR) Cost of Revenue (2024 - 2026)

Updated

Jasper Therapeutics (JSPR) reported Cost of Revenue of $3.58 million for Q2 2026, down 77.3% from $15.77 million a year earlier.

Analysis

Jasper Therapeutics (JSPR) Cost of Revenue (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Jasper Therapeutics' Cost of Revenue came in at $35.46 million; for FY2025, it came in at $41.64 million, up 21.5% from FY2024.

  • By year, Cost of Revenue came in at $34.27 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Jasper Therapeutics 14.32 Mn -112.10 Mn - 3.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.58 Mn
Dec 31, 2025 6.76 Mn
Sep 30, 2025 9.35 Mn
Jun 30, 2025 15.77 Mn
Dec 31, 2024 13.17 Mn
Sep 30, 2024 8.78 Mn
API Access

Jasper Therapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=JSPR&period=max&api_key=YOUR_API_KEY